HowellOWReevesCANicholasRet al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain2011; 134(Pt 9): 2755–2771.
2.
AbsintaMVuoloLRaoAet al. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis. Neurology2015; 85: 18–28.
3.
AbsintaMReichDS. Imaging of meningeal inflammation should become part of the routine MRI protocol – Yes. Mult Scler2019; 25: 330–331.
4.
WattjesMPKillesteinJ. Imaging of meningeal inflammation should become part of the routine MRI protocol – No. Mult Scler2019; 25: 331–333.
5.
RoviraÀWattjesMPTintoréMet al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process. Nat Rev Neurol2015; 11: 471–482.
6.
ZivadinovRRamasamyDPVaneckovaMet al. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study. Mult Scler2017; 23: 1336–1345.
7.
MakshakovGMagonovETotolyanNet al. Leptomeningeal contrast enhancement is associated with disability progression and grey matter atrophy in multiple sclerosis. Neurol Res Int2017; 2017: 8652463.
8.
AbsintaMCorteseICVuoloLet al. Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases. Neurology2017; 88: 1439–1444.
9.
EiselePGriebeMSzaboKet al. Investigation of Leptomeningeal Enhancement in MS: A Postcontrast FLAIR MRI study. Neurology2015; 84: 770–775.
10.
HarrisonDMWangKYFiolJet al. Leptomeningeal enhancement at 7T in multiple sclerosis: Frequency, morphology, and relationship to cortical volume. J Neuroimaging2017; 27: 461–468.
